OOIR: Observatory of International Research

Papers

(The TQCC of Thrombosis Journal is 5. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-06-01 to 2025-06-01.)

Article	Citations
An in situ inferior vena cava ligation-stenosis model to study thrombin generation rates with flow	58
Superior sagittal sinus thrombosis in the course of mixed phenotype acute leukaemia treated with acute lymphoblastic leukaemia-like therapy—a case report	41
Risk of recurrent venous thromboembolism and major bleeding according to risk factor profiles in Asian patients: a subgroup analysis EINSTEIN-Extension and EINSTEIN-CHOICE	35
Balancing the risks: continuous vs. interrupted anticoagulation during TAVI – what does the evidence say?	33
Effect of different balloon pressure band compression regimens on thrombolysis and lower limb venous blood flow velocity in patients undergoing anterograde thrombolysis via the superficial dorsalis pe	32
A snake venom-analog peptide that inhibits SARS-CoV-2 and papain-like protease displays antithrombotic activity in mice arterial thrombosis model, without interfering with bleeding time	25
Association between red cell distribution width-to-lymphocyte ratio and 30-day mortality in patients with ischemic stroke: a retrospective cohort study	24
Application of the Khorana score for cancer-associated thrombosis prediction in patients of East Asian ethnicity undergoing ambulatory chemotherapy	22
Association of elevated circulating monocyte-platelet aggregates with hypercoagulability in patients with nephrotic syndrome	22
Effects of combination therapy of antithrombin and thrombomodulin for sepsis-associated disseminated intravascular coagulation: a systematic review and meta-analysis	21
Monitoring heparin therapy: stability of two different anti-Xa assays using blood samples collected in citrate-containing and CTAD tubes	20
Direct oral anticoagulants versus low molecular weight heparins for the treatment of cancer-associated thrombosis: a cost-effectiveness analysis	20
Prognostic significance of stress hyperglycemia ratio in patients with type 2 diabetes mellitus and acute coronary syndromes	20
Factors associated with thrombosis among solid organ cancer patients in Kuala Lumpur, Malaysia	20
Correction to: The impact on renal function after longterm use of anticoagulants in atrial fibrillation patients	19
The effect of recombinant versus plasma-derived von Willebrand factor on prolonged PFA closure times in ECMO patients with acquired von Willebrand syndrome – an observational study	19
Vaccine-induced thrombotic thrombocytopenia (VITT): first report from India	18
The use of infrared thermography for non-invasive detection of bleeding and musculoskeletal abnormalities in patients with hemophilia: an observational study	16
Low-density lipoprotein cholesterol-to-lymphocyte count ratio (LLR) is a promising novel predictor of postoperative new-onset deep vein thrombosis following open wedge high tibial osteotomy: a propens	16
Comparison between canine and porcine models of chronic deep venous thrombosis	16
Implementation of early prophylaxis for deep-vein thrombosis in intracerebral hemorrhage patients: an observational study from the Chinese Stroke Center Alliance	15
Reduced mortality associated with pulmonary embolism response team consultation for intermediate and high-risk pulmonary embolism: a retrospective cohort study	15
The usefulness of tranexamic acid for bleeding symptoms of chronic consumptive coagulopathy complicated by aortic disease: a single-institute, retrospective study of 14 patients	15
Thrombosis and bleeding outcomes in the treatment of cerebral venous thrombosis in cancer	15
Platelet factor 4 polyanion immune complexes: heparin induced thrombocytopenia and vaccine-induced immune thrombotic thrombocytopenia	15

Postoperative intermittent pneumatic compression for preventing venous thromboembolism in Chinese lung cancer patients: a randomized clinical trial	14
Sex-specific associations between systolic, diastolic and pulse pressure and hemostatic parameters in the population-based KORA-Fit study: a cross-sectional study	14
Lipoxin A4 analogue, BML-111, reduces platelet activation and protects from thrombosis	13
The risk factors of liver cirrhosis complicated with portal vein thrombosis and the efficacy and safety of anticoagulant therapy: a meta analysis	13
Net reclassification index in comparison of prognostic value of disseminated intravascular coagulation diagnostic criteria by Japanese Society on Thrombosis and Hemostasis and International Society on	13
Effect of direct oral anticoagulant therapy on pulmonary artery clot dissolution in intermediate high-risk pulmonary thromboembolism	12
Safety and efficacy of direct oral anticoagulation in patients with and without radiofrequency ablation of non-valvular atrial fibrillation: a multicenter retrospective cohort study	12
Gender-specific relationships between hyperuricemia and idiopathic deep venous thrombosis in the Chinese population: a case‒control study	12
Factors associated with venous thromboembolic disease due to failed thromboprophylaxis	12
Efficacy and safety of oral anticoagulants in elderly patients with stable coronary artery disease and atrial fibrillation	12
Association between obstructive sleep apnea and venous thromboembolism recurrence: results from a French cohort	12
A single-center study of reference intervals for TAT, PIC, TM and t-PAIC in healthy older Chinese adults	12
Treatment of pacemaker-induced superior vena cava syndrome by direct oral anticoagulant	12
Structure, signal transduction, activation, and inhibition of integrin αIIbβ3	12
A case report of spontaneous pectoral hematoma in a male with background antiplatelet therapy after severe COVID-19 infection	11
Correlation between a 2-week change in platelet count and clinical outcomes after the initiation of ravulizumab treatment in adult patients with atypical hemolytic uremic syndrome: post-hoc analysis o	11
SERPINC1 c.1247dupC: a novel SERPINC1 gene mutation associated with familial thrombosis results in a secretion defect and quantitative antithrombin deficiency	11
Clot time ratio (CTR) and relation to treatment outcome in patients with atrial fibrillation treated with Rivaroxaban	11
Identification of key risk factors for venous thromboembolism in urological inpatients based on the Caprini scale and interpretable machine learning methods	11
Aspirin and clopidogrel resistance; a neglected gap in stroke and cardiovascular practice in Iran: a systematic review and meta-analysis	11
Clopidogrel vs. ticagrelor in ST-elevation myocardial infarction complicated by cardiogenic shock undergoing primary PCI	11
Spontaneous rectus sheath hematoma associated with apixaban in an elderly gentleman with chronic obstructive airway disease – a case report	11
The efficacy and safety of direct oral anticoagulants compared with vitamin K antagonist in patients with hypertrophic cardiomyopathy and atrial fibrillation	10
Association of inherited thrombophilia mutations and their combinations among palestinian women with unexplained recurrent miscarriage	10
Platelet adhesion in type 2 diabetes: impact of plasma albumin and mean platelet volume	10
Incidence of peripheral intravenous catheter phlebitis and its associated factors among patients admitted to University of Gondar hospital, Northwest Ethiopia: a prospective, observational study	10
Antithrombotic therapy at discharge and prognosis in patients with chronic coronary syndrome and atrial fibrillation who underwent PCI: a real-world study	10
Clinical trial assessing the safety of edoxaban with concomitant chemotherapy in patients with gynecological cancer-associated thrombosis (EGCAT study)	10
Endovascular revascularization strategies using catheter-based thrombectomy versus conventional catheter-directed thrombolysis for acute limb ischemia	9
Heparin-free after 3000 IU heparin loaded in veno-venous ECMO supported acute respiratory failure patients with hemorrhage risk: a novel anti-coagulation strategy	9
Comparison of the efficacy and safety of rivaroxaban and low-molecular-weight heparin in Chinese lung cancer patients with nonhigh-risk pulmonary embolism	9
Risk factors of thrombosis in Chinese subjects with acute promyelocytic leukemia	9
Replacement of traditional prothrombin time monitoring with the new Fiix prothrombin time increases the efficacy of warfarin without increasing bleeding. A review article	9
Correction: Outcomes of deep venous thrombosis management and associated factors among patients in tertiary hospitals in Addis Ababa, Ethiopia: a multicenter retrospective cohort study	9
Effect of heparin treatment on pulmonary embolism and in-hospital death in unvaccinated COVID-19 patients without overt deep vein thrombosis	9
Agitation-dependent biomechanical forces modulate GPVI receptor expression and platelet adhesion capacity during storage	9
Anticoagulation control, outcomes, and associated factors in long-term-care patients receiving warfarin in Africa: a systematic review	9
A case-control study on factor V Leiden: an independent, gender-dependent risk factor for venous thromboembolism	9
Practical approach to thrombocytopenia in patients with sepsis: a narrative review	8
Causes of death after first time venous thromboembolism	8
NETosis and SARS-COV-2 infection related thrombosis: a narrative review	8
Enhanced in vivo and ex vivo thrombin generation after lower-leg trauma, but not after knee arthroscopy	8
Morphologic change in deep venous thrombosis in the lower extremity after therapeutic anticoagulation	8
Education and clinical pharmacist-led management strategies for the risk and prophylaxis of venous thromboembolism in general surgery	8
Causal inference of sex hormone-binding globulin on venous thromboembolism: evidence from Mendelian randomisation	8
Enoxaparin dosing for venous thromboembolism prophylaxis in hospitalized underweight adult patients: a retrospective cohort study	8
Standard- versus intermediate-dose enoxaparin for anti-factor Xa guided thromboprophylaxis in critically ill patients with COVID-19	8
Laboratory evaluation of a new integrative assay to phenotype plasma fibrinolytic system	7
Comparison of VTE risk scores in guidelines for VTE diagnosis in nonsurgical hospitalized patients with suspected VTE	7
Predictors of pulmonary embolism in hospitalized patients with COVID-19	7

Insulin resistance, metabolic syndrome and micro-RNA-122 serum level in patients with cerebral venous sinus thrombosis: a case-control study	7
Venous thromboembolic disease in admitted blunt trauma patients: what matters?	7
A case of acquired thrombotic thrombocytopenic purpura induced by acute severe hepatitis E: successfully treated by plasma exchange and rituximab	7
Lupus anticoagulant associated with low grade B-cell lymphoma and IgM paraproteinaemia with lupus cofactor phenomenon on DRVVT and SCT assays - a possible novel association	7
A study of recurrent life-threatening thrombosis accompanied with the duplication of the factor IX gene	7
Adrenal hemorrhage following direct oral anticoagulant (DOAC) therapy: two case reports and literature review	7
Pulmonary embolism in a patient with eltrombopag-treated aplastic anaemia and paroxysmal nocturnal haemoglobinuria clone during COVID-19 pneumonia	7
Long noncoding RNA TUG1 induces angiogenesis of endothelial progenitor cells and dissolution of deep vein thrombosis	7
Prevalence of venous thromboembolism and evaluation of a modified caprini risk assessment model: a single-centre, prospective cohort study involving patients undergoing lung resections for bronchiecta	7
Coagulation dysfunction events associated with echinocandins: a real-world study from FDA adverse event reporting system (FAERS) database	7
Incidence of anti-platelet factor4/polyanionic antibodies, thrombocytopenia, and thrombosis after COVID-19 vaccination with ChAdOx1 nCoV-19 in Thais	7
A primary pulmonary artery sarcoma masquerading pulmonary embolism: a case report and literature review	7
Incidence and risk factors of venous thrombotic events in patients with interstitial lung disease during hospitalization	7
Coagulation biomarkers and coronavirus disease 2019 phenotyping: a prospective cohort study	7
Assessing outcomes after thrombectomy with or without iliac vein stenting for young provoked DVT patients with iliac vein stenosis	7
Safety and efficacy of direct oral anticoagulants in stroke prevention in patients with atrial fibrillation complicated with anemia and/or thrombocytopenia: a retrospective cohort study	7
Catheter-directed therapy for pulmonary embolism in pediatrics: a systematic review and meta-analysis	7
Chronic anti-coagulation therapy reduced mortality in patients with high cardiovascular risk early in COVID-19 pandemic	6
Lemierre’s syndrome complicating deep neck abscess: a case report	6
The evolution of clot strength in critically-ill COVID-19 patients: a prospective observational thromboelastography study	6
A retrospective multicenter cohort study of the association between anti-Factor Xa values and death, thromboembolism, and bleeding in patients with critical COVID-19	6
Synergistic effects of rivaroxaban and hypothermia or acidosis on coagulation initiation measured with ROTEM®: a prospective observational study	6
The clinical application of venous ultrasound in diagnosis and follow-up of lower extremity deep vein thrombosis (DVT): a case-based discussion	6
Prediction of residual ischemic risk in ticagrelor-treated patients with acute coronary syndrome	6
External validation and update of the International Medical Prevention Registry on Venous Thromboembolism bleeding risk score for predicting bleeding in acutely ill hospitalized medical patients: a re	6
Frequency of deep vein thrombosis at admission for acute stroke and associated factors: a cross-sectional study	6
“Y appearance” infarction: caused by essential thrombocythemia	6
The effect of neutrophil extracellular traps in venous thrombosis	6
Use of thromboelastography before the administration of hemostatic agents to safely taper recombinant activated factor VII in acquired hemophilia A: a report of three cases	6
Parapneumonic effusion is a risk factor for VTE in hospitalized patients with community-acquired pneumonia: a retrospective cohort study	6
Impact of baseline renal function on the efficacy and safety of different Anticoagulants in Atrial Fibrillation Patients – A cohort study	6
Testing P2Y12 platelet inhibitors generics beyond bioequivalence: a parallel single-blinded randomized trial	5
The effect of Mycobacterium tuberculosis treatment on thrombelastography-assessed haemostasis: a prospective cohort study	5
Causal relationship between varicose veins and mean corpuscular hemoglobin concentration based on Mendelian randomization study	5
Anticoagulation strategy and safety in critically ill COVID-19 patients: a French retrospective multicentre study	5
Evaluation of prothrombotic risk of two PROC hotspot mutations (Arg189Trp and Lys193del) in Chinese population: a retrospective study	5
Clinical characteristics of COVID-19 associated vasculopathic diseases	5
Preventive strategies for hypercoagulation in Cushing’s syndrome: when and how	5
A 11-year-old boy with Blastocystis hominis infection, presents as immune thrombocytopenia	5
Causal association between circulating blood cell traits and pulmonary embolism: a mendelian randomization study	5
Early identification of lung cancer patients with venous thromboembolism: development and validation of a risk prediction model	5
Coagulation dysfunction events associated with tigecycline: a real-world study from FDA adverse event reporting system (FAERS) database	5
A nomogram model for predicting preoperative DVT in elderly anemic patients undergoing total hip arthroplasty: a retrospective cohort study	5
Pregnancy and thrombosis risk for women without a history of thrombotic events: a retrospective study of the real risks	5
Reply to correspondence: Cancer incidence and mortality after a first-ever venous thrombosis in northern Sweden	5
Association between cancer history and second-generation drug-eluting stent thrombosis: insights from the REAL-ST registry	5
Risk factors for thrombolysis-related intracranial hemorrhage: a systematic review and meta-analysis	5
miR-1915-3p regulates megakaryocytic and erythroid differentiation by targeting SOCS4	5
Coagulation abnormalities in childhood acute lymphoblastic leukemia: assessing the impact of L-asparaginase therapy in Ghana	5
LMWHs dosage and outcomes in acute pulmonary embolism with renal insufficiency, an analysis from a large real-world study	5
Monitoring the efficiency of reversal on anti-Xa direct oral anticoagulants using point-of-care viscoelastic testing	5
The prevalence and risk factors of pulmonary embolism in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis	5
Modified thromboelastometric tests provide improved sensitivity and specificity to direct oral anticoagulants compared to standard thromboelastometric tests in-vitro	5